Elan Pharma (India) Pvt. Ltd. (Elan) was created on a foundation of partnership with the goal of collaborating with the medical fraternity to address the unmet healthcare needs of the community by providing innovative pharmaceutical solutions based on excellence in science, quality, and organizational practices. Building Elan along with my colleagues, has been an exhilarating and fulfilling experience. As I look at Elan’s presence and growth in the domestic pharmaceutical industry, I take pride in our associates (Elanites) for what they have achieved by establishing our two major brand groups i.e. RINIFOL (Probiotics) and ORASEP (Stomatologicals) and even more excited about our outlook for an equally promising future. This wouldn’t have been possible without the purpose- and patient-centric mindset of Elanites and manufacturing partners who work diligently to enable us to deliver on our promise of providing “Better Drugs for Better Living”.

Elan’s healthcare products have stood the test of time for more than 4 decades in the pharmaceutical industry. We continue to innovate to address the changing needs and expectations of our customers, and rather than limiting our product portfolio to any one therapeutic area, we provide a wide range of pharmaceutical products covering multiple therapeutic segments which include stomatologicals, haematinics, anti-tussives, probiotics for gastro-intestinal disorders, antacids, NSAIDs, rubefacients, oral healthcare, otologicals, antispasmodics, daily nutritionals, digestive enzymes, dermatologicals, and herbals.; All of these are offered in convenient dosage forms formulated to improve patient acceptance, adherence, and outcomes.

Since Elan’s inception, scientific rigor, quality, and unwavering ethics have been weaved into everything we do, and this has enabled us to establish strong and meaningful relationships with doctors, patients, and stakeholders across India. I am immensely grateful to all of them for the trust and confidence they have placed upon us and for helping us reach the position where we are today. We will persistently build on this robust foundation to reach new heights of excellence in providing innovative pharmaceuticals that will better healthcare.